These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3323617)

  • 1. Mechanisms of hypertension in obesity.
    Dornfeld LP; Maxwell MH; Waks A; Tuck M
    Kidney Int Suppl; 1987 Oct; 22():S254-8. PubMed ID: 3323617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly.
    Ritchie CM; Sheridan B; Fraser R; Hadden DR; Kennedy AL; Riddell J; Atkinson AB
    Q J Med; 1990 Aug; 76(280):855-67. PubMed ID: 2217688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity.
    Dall'Asta C; Vedani P; Manunta P; Pizzocri P; Marchi M; Paganelli M; Folli F; Pontiroli AE
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):110-4. PubMed ID: 18718746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
    Doggrell SA
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):119-25. PubMed ID: 15834464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet.
    Carillo BA; Beutel A; Mirandola DA; Vidonho AF; Furukawa LN; Casarini D; Campos RR; Dolnikoff MS; Heimann JC; Bergamaschi CT
    Regul Pept; 2007 Apr; 140(1-2):5-11. PubMed ID: 17196676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
    Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
    J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of obesity-related hypertension.
    Lamounier-Zepter V; Bornstein SR; Ehrhart-Bornstein M
    Horm Metab Res; 2004 Jun; 36(6):376-80. PubMed ID: 15241727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.